Evidence map›Paper›PMID 35730163›Full record

ArticleInternational forum of allergy & rhinology2022

Indications for absorbable steroid-eluting sinus implants: Viewpoint via the Delphi method.

Victoria S Lee, Prayag Patel, Daniel O'Brien, George A Scangas, Raewyn G Campbell, Rakesh Chandra, Greg E Davis, Joseph K Han, Christopher H Le, Jivianne Lee and 8 more

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in International forum of allergy & rhinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Assessing the effect of absorbable steroid sinus implant: a state-of-the-art systematic review.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Pooled it
  2. Article
  3. Bioabsorbable steroid-eluting implants in high-risk primary and revision frontal sinus surgery: real-world outcomes at a UK tertiary centre.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  4. Management of pott's puffy tumor: a Delphi-method international clinical consensus statement.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Victoria S LeeDepartment of Otolaryngology - Head and Neck Surgery, University of Illinois Chicago, Chicago, Illinois, USA.ORCID 0000-0003-3221-126X
Prayag PatelDepartment of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Daniel O'BrienDivision of Otolaryngology - Head and Neck Surgery, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-8394-9902
George A ScangasDepartment of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA.
Raewyn G CampbellDepartment of Otolaryngology Head and Neck Surgery, Macquarie University, Sydney, Australia.
Rakesh ChandraDepartment of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Greg E DavisProliance Surgeons, Seattle and Puyallup WA, Seattle, Washington, USA.
Joseph K HanDepartment of Otolaryngology Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, USA.
Christopher H LeDepartment of Otolaryngology - Head and Neck Surgery, University of Arizona College of Medicine, Tucson, Arizona, USA.
Jivianne LeeDepartment of Head and Neck Surgery, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA.
Amber U LuongDepartment of Otorhinolaryngology - Head and Neck Surgery, McGovern Medical School of the University of Texas Health Science Center at Houston, Houston, Texas, USA.ORCID 0000-0001-6078-8010
David M PoetkerDepartment of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Hassan RamadanDepartment of Otolaryngology - Head & Neck Surgery, West Virginia University, Morgantown, West Virginia, USA.
Michael SetzenMichael Setzen Otolaryngology, PC, Great Neck, NY, Weill Cornell Medical College, New York, New York, USA.
Kristine SmithDepartment of Otolaryngology - Head & Neck Surgery, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-7026-5819
Sarah WiseDepartment of Otolaryngology-Head and Neck Surgery, Emory University, Atlanta, Georgia, USA.
Jennifer VillwockDepartment of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, Kansas, USA.ORCID 0000-0001-5645-4210
Elisabeth FerenceCaruso Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.ORCID 0000-0002-4177-6716

Funding

Institutional Career Development CoreKL2TR002367 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MATTHEW W MOSCONI, NICOLE L NOLLEN · 2017 to 2026
$7.3M
NCATS NIH HHS KL2 TR002367
6 · The paper itself

Abstract

Absorbable steroid-eluting sinus implants provide targeted corticosteroid release over a sustained period and are designed to prevent both undesirable adhesion formation and sinus ostia restenosis. Here, we highlight the key evidence of these implants to date and query a group of experts via a Delphi process on the indications and optimal timing for intraoperative or in-office placement of these implants. Six of a total of 12 statements reached consensus and were accepted. Overall, experts largely agree that intraoperative or in-office use of steroid-eluting stents could be considered for patients: (1) who are diabetic or intolerant of oral steroids, (2) undergoing extended frontal sinus surgery, and (3) with recurrent stenosis. Given the lack of expert consensus on other key statements, clinicians should carefully consider these treatment options on a case-by-case basis after shared decision-making.

Indexed as

RhinitisSinusitisAbsorbable ImplantsAdrenal Cortex HormonesChronic DiseaseDelphi TechniqueEndoscopyHumansSteroidsTreatment OutcomeAdrenal Cortex HormonesSteroidsendoscopic sinus surgeryPROPELSINUVAsteroid-eluting implants

Identifiers

PMID35730163
PMCPMC10108565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.